Tela Bio appoints Jeffrey Blizard as president, effective immediately

TELA Bio (TELA) announced the appointment of Jeffrey Blizard as President of TELA Bio, effective immediately. Blizard has served on TELA Bio’s Board of Directors for the past year. “This is an important inflection point for TELA Bio,” said Antony Koblish, Co-Founder and CEO of TELA Bio. “As we move into the next phase of our growth trajectory, we believe the addition of Jeff-a highly respected leader with a track record of scaling businesses and inspiring teams-will amplify our ability to compete and win in a dynamic market. We are confident that this leadership evolution will drive meaningful commercial performance and reinforce our commitment to delivering exceptional value to our customers, partners, and shareholders.” Blizard joins TELA Bio from Abiomed, a Johnson & Johnson (JNJ) company, where he served as Global Head of Surgical Sales.